Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02079662 · ClinicalTrials.gov registry record · NA
The Role of Lifestyle Factors in Breast Cancer-Related Outcomes
A NA study of Stage II Breast Cancer AJCC v6 and v7 and Stage IIA Breast Cancer AJCC v6 and v7, sponsored by M.D. Anderson Cancer Center.
- Active
- Registry status
- NA
- Development phase
- 110
- Enrollment target
- 1
- Study location
NCT02079662 is a NA study of Stage II Breast Cancer AJCC v6 and v7 and Stage IIA Breast Cancer AJCC v6 and v7 that is active but no longer recruiting, run by M.D. Anderson Cancer Center. The registered enrollment target is 110 participants, below the 354-participant average among 11 other Stage II Breast Cancer AJCC v6 and v7 trials with a reported enrollment target (69% lower). The trial reports 1 study location across 1 state.
The verdict
NCT02079662, a NA study of Stage II Breast Cancer AJCC v6 and v7 and Stage IIA Breast Cancer AJCC v6 and v7, is active but no longer recruiting, sponsored by M.D. Anderson Cancer Center.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 110 participants
- Enrollment target
- 1
- Study location
Study Summary
This randomized clinical trial studies an integrative oncology (making changes in lifestyle and behavior) program in improving cancer-related outcomes in patients with stage II or III breast cancer undergoing radiation therapy. An integrative oncology program consisting of dietary recommendations, physical activity, stress management, social support, and control of environmental contaminants may modify cancer-related biological processes, influence long-term treatment results, and improve the quality of life of patients.
Conditions Studied
Interventions
- OTHER Best Practice
- OTHER Counseling
- OTHER Cognitive Intervention
- OTHER Behavioral, Psychological or Informational Intervention
- OTHER Computer-Assisted Intervention
Study Locations (1)
Texas
- M D Anderson Cancer Center - Houston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 110 participants |
| Start Date | 2013-06-13 |
| Est. Completion | 2030-12-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02079662
The ClinicalTrials.gov registry entry for NCT02079662 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 110 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 354-participant average among 11 other Stage II Breast Cancer AJCC v6 and v7 trials with a reported enrollment target (69% lower). The listed sponsor is M.D. Anderson Cancer Center, which has 2,692 total studies on file at ClinicalTrials.gov.
The record links to 7 conditions, with Stage II Breast Cancer AJCC v6 and v7 appearing as the primary indexed condition, and to 5 interventions - of which Best Practice is the first listed.
NCT02079662 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.
Frequently Asked Questions
What is clinical trial NCT02079662 about?
NCT02079662 is a clinical study titled "The Role of Lifestyle Factors in Breast Cancer-Related Outcomes". This randomized clinical trial studies an integrative oncology (making changes in lifestyle and behavior) program in improving cancer-related outcomes in patients with stage II or III breast cancer undergoing radiation therapy. An integrative oncology program consisting of dietary recommendations, p...
What is the current status of trial NCT02079662?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 110 participants. The study started on 2013-06-13. Estimated completion is 2030-12-31.
What conditions does trial NCT02079662 study?
This clinical trial studies the following conditions: Stage II Breast Cancer AJCC v6 and v7, Stage IIA Breast Cancer AJCC v6 and v7, Stage III Breast Cancer AJCC v7, Stage IIIC Breast Cancer AJCC v7, Stage IIB Breast Cancer AJCC v6 and v7.
What interventions are being tested in trial NCT02079662?
The interventions under investigation include: Best Practice (OTHER), Counseling (OTHER), Cognitive Intervention (OTHER), Behavioral, Psychological or Informational Intervention (OTHER), Computer-Assisted Intervention (OTHER).
Who is sponsoring clinical trial NCT02079662?
This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02079662 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Stage II Breast Cancer AJCC v6 and v7
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Multicenter Trial for Eliminating Breast Cancer Surgery or Radiotherapy in Exceptional Responders to Neoadjuvant Systemic Therapy
RECRUITING · NA
-
Molecular Testing and Imaging in Improving Response in Patients With Stage I-III Triple-Negative Breast Cancer Receiving Chemotherapy MDACC Breast Moonshot Initiative
ACTIVE NOT RECRUITING · NA
-
Phase I Trial of Endoxifen Gel Versus Placebo in Women Undergoing Breast Surgery
ACTIVE NOT RECRUITING · Phase 1
-
Hypofractionated Radiation Therapy or Standard Radiation Therapy in Treating Patients With Ductal Breast Carcinoma In Situ or Early Invasive Breast Cancer
ACTIVE NOT RECRUITING · Phase 2
-
Multi-epitope Folate Receptor Alpha Peptide Vaccine, GM-CSF, and Cyclophosphamide in Treating Patients With Triple Negative Breast Cancer
ACTIVE NOT RECRUITING · Phase 2
-
Hypofractionated vs. Conventional Regional Nodal Radiation Therapy for Patients With Invasive Breast Cancer
ACTIVE NOT RECRUITING · Phase 2
Explore more on PlainTrial
Stage II Breast Cancer AJCC v6 and v7
All registered trials for this condition
Stage IIA Breast Cancer AJCC v6 and v7
All registered trials for this condition
Texas
All trials with a study site in Texas
Recruiting now
Find trials open to new participants near you
Rankings
Top sponsors, conditions, and phases
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.